Valuation: Middle East Pharmaceutical Industries Company

Market Cap 2.12B 564M 493M 455M 419M 791M 54.29B 806M 5.43B 2.13B 26.52B 2.07B 91.49B P/E 2024
30.5x
P/E 2025 22.9x
Enterprise Value 2.15B 571M 500M 462M 424M 802M 55.05B 817M 5.51B 2.16B 26.89B 2.1B 92.77B EV / Sales 2024
6.29x
EV / Sales 2025 4.89x
Free-Float
43.12%
Yield 2024
1.64%
Yield 2025 2.18%
1 day-0.74%
1 week-1.47%
Current month-0.08%
1 month-2.66%
3 months-0.29%
6 months-4.52%
Current year-4.87%
1 week 60.4
Extreme 60.4
64.15
1 month 58.35
Extreme 58.35
64.5
Current year 53.89
Extreme 53.8857
68.51
1 year 53.89
Extreme 53.8857
79.09
3 years 51.54
Extreme 51.5429
112.91
5 years 51.54
Extreme 51.5429
112.91
10 years 51.54
Extreme 51.5429
112.91
Manager TitleAgeSince
Chief Executive Officer 45 05/09/2018
Director of Finance/CFO - 11/03/2024
Chief Tech/Sci/R&D Officer 51 01/01/2023
Director TitleAgeSince
Director/Board Member 64 05/03/2023
Director/Board Member 45 13/09/2023
Chairman 54 10/04/2022
Change 5-day change 1-year change 3-year change Capi.($)
-0.74%-1.47%-11.92% - 568M
-0.07%+3.28%+12.89%+81.75% 48.66B
+0.59%-1.21%+67.38%+116.30% 35.52B
-0.59%-0.16%-4.12%+38.67% 12.07B
-0.26%+0.51%+19.25%+93.82% 11.99B
0.00%+2.29%+34.34%+129.06% 9.29B
-1.76%-5.73%+41.23%-7.49% 6.92B
+0.50%+0.50%+19.50%+37.94% 7B
-0.46%+2.84%+2.73%+225.72% 6.74B
+7.04%+14.92%-10.65%+29.12% 6.36B
Average +0.42%+1.54%+17.06%+82.77% 14.51B
Weighted average by Cap. +0.27%+1.42%+26.78%+88.68%

Financials

2024 2025
Net sales 394M 105M 91.75M 84.82M 77.94M 147M 10.11B 150M 1.01B 397M 4.94B 385M 17.04B 460M 123M 107M 99.13M 91.09M 172M 11.82B 175M 1.18B 464M 5.77B 450M 19.91B
Net income 79.85M 21.27M 18.59M 17.19M 15.8M 29.86M 2.05B 30.4M 205M 80.42M 1B 78.11M 3.45B 97.01M 25.84M 22.59M 20.88M 19.19M 36.27M 2.49B 36.93M 249M 97.71M 1.22B 94.9M 4.19B
Net Debt 42.83M 11.41M 9.97M 9.22M 8.47M 16.02M 1.1B 16.31M 110M 43.14M 537M 41.9M 1.85B 29.47M 7.85M 6.86M 6.34M 5.83M 11.02M 756M 11.22M 75.65M 29.69M 369M 28.83M 1.27B
Logo Middle East Pharmaceutical Industries Company
Middle East Pharmaceutical Industries Company SJSC is a Saudi Arabia-based pharmaceutical company. The Company develops, manufactures, markets, and distributes a wide range of generic medicines and pharmaceuticals. The Company’s activity is the manufacture of disinfectants and sterilizers for medical devices and products, the manufacture of disinfectants and sterilizers for non-medical use, the manufacture of cosmetics, and the manufacture of pharmaceutical preparations for human use.
Employees
731
Date Price Change Volume
16/07/26 SAR 60.45 -0.74% 27,291
15/07/26 SAR 60.90 -2.25% 145,954
14/07/26 SAR 62.30 -1.11% 41,345
13/07/26 SAR 63.00 +1.12% 53,500
12/07/26 SAR 62.30 -1.11% 81,238
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
B
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
60.45SAR
Average target price
83.66SAR
Spread / Average Target
+38.39%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 4016 Stock